Therapeutic Asset Ratings
8,400 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Epirubicin
Stage IVB Bladder Cancer AJCC v8
M.D. Anderson Cancer Center
P1/2
B
(57)
ETOPOSIDE
Metastatic Neoplasm
Shanghai Runshi Pharmaceutical Technology Co., Ltd
P1/2
B
(57)
ETOPOSIDE
Hairy Cell Leukemia
City of Hope Medical Center
P1/2
B
(57)
EVUZAMITIDE
Primary Systemic Amyloidosis
University of Tennessee Graduate School of Medicine
P1/2
B
(57)
FILGRASTIM
Locally Advanced Gastric Adenocarcinoma
Mayo Clinic
P1/2
B
(57)
flt201
Gaucher Disease, Type 1
Spur Therapeutics
P1/2
B
(57)
Fludarabine
CD19 Positive
Jonsson Comprehensive Cancer Center
P1/2
B
(57)
Fludarabine
Germ Cell Tumor
M.D. Anderson Cancer Center
P1/2
B
(57)
Fludarabine
HER2 Positive Gastric Cancer
Dispatch Biotherapeutics
P1/2
B
(57)
Fludarabine
Lung Adenocarcinoma
Anusha Kalbasi
P1/2
B
(57)
Fludarabine
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Peking University People's Hospital
P1/2
B
(57)
FLUTICASONE
Locally Advanced Gastric Adenocarcinoma
Mayo Clinic
P1/2
B
(57)
gc101
Efficacy
Shanghai Juncell Therapeutics
P1/2
B
(57)
gc101
Safety
Shanghai Juncell Therapeutics
P1/2
B
(57)
Gdc-0449
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
P1/2
B
(57)
HUMAN FAECAL MATTER
Alcohol Abuse
Virginia Commonwealth University
P1/2
B
(57)
Hycamtin
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1/2
B
(57)
Idarubicine
Acute Myeloid Leukemia With Multilineage Dysplasia
University of Southern California
P1/2
B
(57)
ima203
Cancer
Immatics US, Inc.
P1/2
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL CAN04 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CAN04 .KAPPA.-CHAIN, DIMER
Non-Small Cell Lung Carcinoma
Cantargia AB
P1/2
B
(57)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Composite Lymphoma
M.D. Anderson Cancer Center
P1/2
B
(57)
Inno-206
Prolymphocytic Leukemia
Acerta Pharma BV
P1/2
B
(57)
Inotuzumab Ozogamicin
Burkitt Lymphoma
SWOG Cancer Research Network
P1/2
B
(57)
JAB 3312
Pancreatic Ductal Adenocarcinoma
Allist Pharmaceuticals, Inc.
P1/2
B
(57)
MAT2A-IN-9
Non-Small Cell Lung Carcinoma
IDEAYA Biosciences
P1/2
B
(57)
Showing 126 to 150 of 8,400 assets
Previous
Page 6 of 336
Next
